Source: International Congress 2018 – Novel immunology-based therapies in asthma and COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Armitage (Perth, Australia), D. Tan (Perth, Australia), R. Troedson (Perth, Australia), P. Young (Perth, Australia), K. Lam (Perth, Australia), K. Shaw (Perth, Australia), M. Sturm (Perth, Australia), D. Weiss (Vermont, United States of America), Y. Moodley (Perth, Australia). Systemic immunological changes following intravenous mesenchymal stromal cell infusion in stable COPD patients. 1653

Member's Comments

No comment yet.

Related content which might interest you: Mesenchymal stromal cell infusion modulates systemic immunological responses in stable COPD patients: a phase I pilot study Source: Eur Respir J, 51 (3) 1702369; 10.1183/13993003.02369-2017 Year: 2018 Pulmonary infiltrates in hematopoietic stem cell trasplantation (HSCT) recipients. Associated pulmonary and systemic inflammatory response Source: Eur Respir J 2003; 22: Suppl. 45, 334s Year: 2003 Oral presentation: Increased CXCR4 expression and short telomeres in bone marrow mesenchymal stem cells of patients with idiopathic pulmonary fibrosis Source: Lung Science Conference 2009 - Cell proliferation, Differentiation and Carcinogenesis Year: 2009 Effects of autologous mesenchymal stromal cell treatment for severe emphysema on lung tissue: A clinical trial Source: International Congress 2015 – The multiple facets of stem and progenitor cells in lung health and disease Year: 2015 Intratracheal versus intravenous bone marrow mononuclear cell therapy in pulmonary and extrapulmonary acute lung injury: Which is the best administration route? Source: Annual Congress 2010 - Acute lung injury and ventilator-induced lung injury Year: 2010 Mesenchymal stem cell therapy in a model of chronic inflammatory lung disease Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair Year: 2019 Diagnostic value of bronchoalveolar lavage cell differentiation in patients with pulmonary complications after high dose chemotherapy and hematopoietic stem cell transplantation Source: Eur Respir J 2002; 20: Suppl. 38, 471s Year: 2002 Late Breaking Abstract - High cumulative dose of allogeneic mesenchymal stem cells in patients with progressive idiopathic pulmonary fibrosis Source: International Congress 2019 – Translational aspects of idiopathic interstitial pneumonia Year: 2019 Late-breaking abstract: Comparison of bone marrow derived-mononuclear cells with mesenchymal stem cells on inflammatory and remodeling processes in experimental chronic allergic asthma Source: Annual Congress 2011 - Late-Breaking Abstracts Session: New mechanisms in airway disease Year: 2011 Treating systemic sclerosis with lung involvement: from observation to stem cell transplantation Source: International Congress 2018 – Respiratory medicine meets rheumatology Year: 2018 Both intranasal and intraperitoneal administration of human tubal mesenchymal stem cells (htMSC) ameliorates experimental COPD model Source: International Congress 2014 – Animal models in respiratory drug development Year: 2014 Fibroblastic activity of sputum in COPD, patients undergoing hematopoietic stem cell transplantation and healthy subjects Source: Annual Congress 2010 - Mechanisms and modulation of allergic inflammation in the lung Year: 2010 Changes in lung volumes and airway responsiveness following haematopoietic stem cell transplantation Source: Eur Respir J 2008; 32: 1576-1582 Year: 2008 Venous infusion of mesenchymal stem cells reduces the inflammation induced by recurrent obstructive apneas Source: Annual Congress 2010 - Sleep apnoea: insights from basic and clinical research Year: 2010 Therapeutic potential of mesenchymal stem cells to attenuate immune cell tolerance in a late stage model of sepsis Source: Virtual Congress 2020 – Physiological and cellular mechanisms affecting pulmonary pathologies Year: 2020 Aerosolised delivery of mesenchymal stromal cells to the lungs: towards a novel therapy Source: International Congress 2017 – Repair of the emphysematous lung: mesenchymal stromal cell and matrix interactions Year: 2017 Increased expression of TERT mRNA expresssion in bone marrow-derived mesenchymal stem cells (BM-MSCs) in patients with chronic obstructive pulmonary disease (COPD): Preliminary results Source: Annual Congress 2010 - Novel mechanisms in COPD Year: 2010 Comparative effects of inhaled and intravenous mesenchymal stem cells in bleomycin-induced pulmonary fibrosis in rabbits Source: Annual Congress 2013 –Cutting edge: drug delivery to the airways Year: 2013 LSC 2010 Abstract: Does cigarette smoking influence bone marrow microenvironment? Down-regulation of CXCR4 expression in bone marrow-derived mesenchymal stem cells (BM-MSCs) in patients with chronic obstructive pulmonary disease (COPD): preliminary results Source: Annual Congress 2010 - Novel mechanisms in COPD Year: 2010 Protective roles of paracrine factors of bone marrow mesenchymal stem cells in bleomycin induced lung epithelial cell injury in vitro and pulmonary fibrosis in vivo Source: Annual Congress 2010 - Experimental approaches in pulmonary fibrosis Year: 2010